DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Garaventa A, Bellagamba O, Lo Piccolo MS. et al.
131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
Br J Cancer 1999;
81: 1378-1384
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.